Fast MDx is a Social Enterprise that aims to open up the Molecular Diagnostic (MDx) test market

Economies of scale will allow for the first time, Molecular Diagnostic testing to become available to all economies not just High-Income countries

The massive benefits of Molecular Diagnostic testing become available in all economies not just in the High-Income countries and to emphasise this Fast MDx as a Social Enterprise will pay for free testing in Low- and Middle-Income countries from a percentage of its profits

As the platform is mobile it can be used in remote environments and so will offer for the first time the benefits of fast, accurate, Molecular Diagnostic testing to all people, in all economies and vastly more locations around the World

Fully automated testing is far more accurate that manual testing on modular systems, as computers and robotic systems never get bored, distracted, or tired

Assist clinicians to prescribe and treat accurately

Less re-testing of indeterminate results

Medium- to High-Throughput Testing with sample-to-result in under 2 hours

1000+ test results per 8 hours

Faster clinical pathways – earlier and better intervention will produce better outcomes

Reduced spread of disease throughout society by earlier quarantining

Fast MDx can be run more locally and can complete  automated testing in similar volumes to those processed in expensive, complex, bio-secure, centralised laboratories either using multiple cheaper modular or very large and expensive semi-automated platforms

One Fast MDx platform and technician provide the same as five biomedical scientists in a biosecure laboratory

Fast MDx testing will be sold on a reagent rental basis, with the Fast MDx platform lent Free of Charge and only the low-cost tests being chargeable

Reduced overhead costs

Reduced logistic costs

Minimal packaging costs

Much lower staffing costs

No capital expenditure

No barrier to entry

Without the need to move samples over long distances, fewer people are involved in handling the samples, no vehicle fuels are used and so no Green Houses gases are emitted

The ultra-fast, NGx2 4-Channel qPCR thermal cycler uses less electricity per sample than any other thermal cycler

Reduced packaging without the need for one-use carboard boxing, tape and plastics as well as the need to store and the  incineration of packaging materials

Less vehicle emissions and drastically reduced carbon footprint

Less plastics used to mass test, especially when compared with all single use cartridge test systems

Fast MDx eliminates the need for one-use packaging, as well as its storing and subsequent incineration

One technician operating a Fast MDx, does the work of several biomedical scientists in expensive biosecure laboratory and so drastically reduces the carbon footprint where the Fast MDx is being operated as well as the biosecure human facilities required by the several biomedical scientists